Carisoprodol Intoxications and Serotonergic Features

References

• Berger F, Kletzkin M, Ludwig B, Margolin S. The history, chemistry, and pharmacology of carisoprodol. Ann N Y Acad Sci 1959; 86:90–107.
   Web of Science ®Google Scholar
• Brandslund I. A case of acute carisoprodol poisoning. Symptoms and metabolism. Ugeskr Laeger 1976; 138(5):281–283.
   PubMedGoogle Scholar
• Olsen H, Koppang E, Alvan G, Mørdand J. Carisoprodol elimination in humans. Ther Drug Monit 1995; 16:337–340.
   Web of Science ®Google Scholar
• Dalen P, Alvan G, Wakelkamp M, Olsen H. Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Pharmacogenetics 1996; 6(5):387–394.
   PubMedGoogle Scholar
• del Castillo J, Nelson T. The mode of action of carisoprodol. Ann N Y Acad Sci 1960; 86:108–142.
   PubMed Web of Science ®Google Scholar
• Goth A, Shore P. Medical Pharmacology. Mosby: St. Louis, 1978.
   Google Scholar
• Elenbaas J K. Centrally acting oral skeletal muscle relaxants. Am J Hosp Pharm 1980; 37(10):1313–1323.
   PubMedGoogle Scholar
• Littrell R A, Hayes L R, Stillner V. Carisoprodol (Soma): a new and cautious perspective on an old agent. South Med J 1993; 86(7):753–756.
   PubMed Web of Science ®Google Scholar
• Hobbs W, Rall T, Verdoorn T. Hypnotics and sedatives: ethanol. In: Hardman J, Limbird L, eds. Goodman & Gilman's Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1995:361–396.
   Google Scholar
• Ashford J, Cobby J. The effects of alcohol and meprobamate applied singly and jointly in human subjects. III. The concentrations of alcohol and meprobamate in blood and their effects on performance; application of mathematical models. J Stud Alcohol, Suppl 1975; 7:140–161.
   PubMedGoogle Scholar
• Rho J M, Donevan S D, Rogawski M A. Barbiturate-like actions of the propanediol dicarbamates felbamate and meprobamate. J Pharmacol Exp Ther 1997; 280(3):1383–1391.
   PubMed Web of Science ®Google Scholar
• Roache J D, Griffiths R R. Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. J Pharmacol Exp Ther 1987; 243(3):978–988.
   PubMed Web of Science ®Google Scholar
• Bailey D N, Briggs J R. Carisoprodol: an unrecognized drug of abuse. Am J Clin Pathol 2002; 117(3):396–400.
   PubMed Web of Science ®Google Scholar
• Elder N C. Abuse of skeletal muscle relaxants. Am Fam Phys 1991; 44(4):1223–1226.
   PubMed Web of Science ®Google Scholar
• Lebby T I, Dugger K, Lipscomb JW, Leikin JB. Skeletal muscle relaxant ingestion. Vet Hum Toxicol 1990; 32(2):133–135.
   PubMedGoogle Scholar
• Littrell R A, Sage T, Miller W. Meprobamate dependence secondary to carisoprodol (Soma) use. Am J Drug Alcohol Abuse 1993; 19(1):133–134.
   PubMed Web of Science ®Google Scholar
• Morse R M, Chua L. Carisoprodol dependence: a case report. Am J Drug Alcohol Abuse 1978; 5(4):527–530.
   PubMed Web of Science ®Google Scholar
• Rust G S, Hatch R, Gums J G. Carisoprodol as a drug of abuse. Arch Fam Med 1993; 2(4):429–432.
   PubMedGoogle Scholar
• Wyller T, Korsmo G, Gadeholt G. Carisoprodol-dependence. A prospective withdrawal study among prisoners. Tidsskr Nor Laegeforen 1991; 111(2):193–195.
   PubMedGoogle Scholar
• Hollister L E. The pre-benzodiazepine era. J Psychoact Drugs 1983; 15(1–2):9–13.
   PubMed Web of Science ®Google Scholar
• Goldberg D. Carisoprodol toxicity. Mil Med 1969; 134:597–601.
   PubMed Web of Science ®Google Scholar
• Roth B A, Vinson D R, Kim S. Carisoprodol-induced myoclonic encephalopathy. J Toxicol, Clin Toxicol 1998; 36(6):609–612.
   PubMed Web of Science ®Google Scholar
• Bramness J, Skurtveit S, Mørland J. Impairment due to intake of carisoprodol. Drug Alcohol Depend 2004; 74(3):311–318.
   PubMed Web of Science ®Google Scholar
• Roberge R J, Lin E, Krenzelok E P. Flumazenil reversal of carisoprodol (Soma) intoxication. J Emerg Med 2000; 18(1):61–64.
   PubMed Web of Science ®Google Scholar
• Shane A, Hirsch S. Three cases of meprobamate poisoning. Canad MAJ 1956; 74:908–909.
   PubMedGoogle Scholar
• Bedson H. Coma due to meprobamate intoxication. Report of a case confirmed by chemical analysis. Lancet 1959; 273(1):288–290.
   Google Scholar
• Allen M D, Greenblatt D J, Noel B J. Meprobamate overdosage: a continuing problem. Clin Toxicol 1977; 11(5):501–515.
   PubMed Web of Science ®Google Scholar
• Blumberg A, Rosett H, Dobrow A. Severe hypotension reactions following meprobamate overdosage. Ann Intern Med 1959; 51:607–612.
   PubMed Web of Science ®Google Scholar
• Jacobsen D, Wiik-Larsen E, Saltvedt E, Bredesen JE. Meprobamate kinetics during and after terminated hemoperfusion in acute intoxications. J Toxicol, Clin Toxicol 1987; 25(4):317–331.
   PubMed Web of Science ®Google Scholar
• Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148(6):705–713.
   PubMed Web of Science ®Google Scholar
• Hegerl U, Bottlender R, Gallinant J, Kurs HJ, Ackenheil M, Moller HJ. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 1998; 248(2):96–103.
   PubMed Web of Science ®Google Scholar
• Kaneda Y, Ohmori T, Fujii A. The serotonin syndrome: investigation using the Japanese version of the Serotonin Syndrome Scale. Psychiatry Res 2001; 105(1–2):135–142.
   PubMed Web of Science ®Google Scholar
• Radomski J W, Dursan S M, Reveley M A, Kutcher S P. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 2000; 55(3):218–224.
   PubMed Web of Science ®Google Scholar
• Kucharczyk N, Segelman FH, Kelton E, Summers J, Sofia RD, Mahrous H, Heath R. Gas chromatographic determination of carisoprodol in human plasma. J Chromatogr 1986; 377:384–390.
   PubMed Web of Science ®Google Scholar
• Gaillard Y, Billault F, Pepin G. Meprobamate overdosage: a continuing problem. Sensitive GC-MS quantitation after solid phase extraction in 19 fatal cases. Forensic Sci Int 1997; 86(3):173–180.
   PubMed Web of Science ®Google Scholar
• Lhoste F, Lemaire F, Rapin M. Treatment of hypotension in meprobamate poisoning. N Engl J Med 1977; 296(17):1004.
   PubMed Web of Science ®Google Scholar
• Li P, Zhuo M. Cholinergic, noradrenergic, and serotonergic inhibition of fast synaptic transmission in spinal lumbar dorsal horn of rat. Brain Res Bull 2001; 54(6):639–647.
   PubMed Web of Science ®Google Scholar
• Sandyk R. L-Dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine. J Clin Psychopharmacol 1986; 6:194–195.
   PubMed Web of Science ®Google Scholar
• Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998; 16(4):615–619.
   PubMedGoogle Scholar
• Lappin R, Auchinloss E. Treatment of the serotonin syndrome with cyproheptadine. N Engl J Med 1994; 331:1021–1022.
   PubMed Web of Science ®Google Scholar
• Guze B, Baxter L J. The serotonin syndrome: case responsive to propanolol. J Clin Psychopharmacol 1986; 6:119–120.
   PubMed Web of Science ®Google Scholar
• Logan B K, Case G A, Gordon A M. Carisoprodol, meprobamate, and driving impairment. J Forensic Sci 2000; 45(3):619–623.
   PubMed Web of Science ®Google Scholar